1. Home
  2. LAB vs KIO Comparison

LAB vs KIO Comparison

Compare LAB & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAB
  • KIO
  • Stock Information
  • Founded
  • LAB 1999
  • KIO 2011
  • Country
  • LAB United States
  • KIO United States
  • Employees
  • LAB N/A
  • KIO 2400
  • Industry
  • LAB Biotechnology: Laboratory Analytical Instruments
  • KIO Investment Managers
  • Sector
  • LAB Industrials
  • KIO Finance
  • Exchange
  • LAB Nasdaq
  • KIO Nasdaq
  • Market Cap
  • LAB 462.4M
  • KIO 506.5M
  • IPO Year
  • LAB 2011
  • KIO N/A
  • Fundamental
  • Price
  • LAB $1.24
  • KIO $12.48
  • Analyst Decision
  • LAB Buy
  • KIO
  • Analyst Count
  • LAB 2
  • KIO 0
  • Target Price
  • LAB $2.50
  • KIO N/A
  • AVG Volume (30 Days)
  • LAB 2.8M
  • KIO 136.5K
  • Earning Date
  • LAB 07-30-2025
  • KIO 01-01-0001
  • Dividend Yield
  • LAB N/A
  • KIO 10.82%
  • EPS Growth
  • LAB N/A
  • KIO N/A
  • EPS
  • LAB N/A
  • KIO N/A
  • Revenue
  • LAB $169,687,000.00
  • KIO N/A
  • Revenue This Year
  • LAB N/A
  • KIO N/A
  • Revenue Next Year
  • LAB $12.18
  • KIO N/A
  • P/E Ratio
  • LAB N/A
  • KIO N/A
  • Revenue Growth
  • LAB 33.86
  • KIO N/A
  • 52 Week Low
  • LAB $0.92
  • KIO $10.52
  • 52 Week High
  • LAB $2.41
  • KIO $13.59
  • Technical
  • Relative Strength Index (RSI)
  • LAB 52.66
  • KIO 55.36
  • Support Level
  • LAB $1.27
  • KIO $12.44
  • Resistance Level
  • LAB $1.41
  • KIO $12.58
  • Average True Range (ATR)
  • LAB 0.08
  • KIO 0.06
  • MACD
  • LAB -0.00
  • KIO -0.02
  • Stochastic Oscillator
  • LAB 38.46
  • KIO 31.25

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

About KIO KKR Income Opportunities Fund

KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.

Share on Social Networks: